| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.36T | 579.72B | 559.76B | 550.02B | 555.86B |
| Gross Profit | 724.17B | 579.72B | 694.64B | 550.02B | 555.86B |
| EBITDA | 347.60B | 342.40B | 0.00 | 326.68B | 315.24B |
| Net Income | 291.04B | 282.08B | 269.36B | 259.23B | 241.18B |
Balance Sheet | |||||
| Total Assets | 48.78T | 43.24T | 39.87T | 33.93T | 29.07T |
| Cash, Cash Equivalents and Short-Term Investments | 4.57T | 3.35T | 4.57T | 3.76T | 3.08T |
| Total Debt | 3.62T | 692.88B | 2.68T | 2.20T | 1.80T |
| Total Liabilities | 45.54T | 40.14T | 36.98T | 31.25T | 26.65T |
| Stockholders Equity | 3.24T | 3.09T | 2.89T | 2.67T | 2.41T |
Cash Flow | |||||
| Free Cash Flow | 2.09T | 1.33T | 1.80T | 1.30T | 213.58B |
| Operating Cash Flow | 2.11T | 1.35T | 1.83T | 1.32T | 239.62B |
| Investing Cash Flow | -2.07T | -2.24T | -1.33T | -1.05T | -331.24B |
| Financing Cash Flow | 352.95B | 225.63B | 5.20T | 298.22B | 54.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.27T | 5.23 | 9.77% | 5.64% | -4.61% | 0.94% | |
76 Outperform | HK$2.60T | 6.66 | 9.18% | 4.81% | -2.85% | 10.49% | |
75 Outperform | HK$1.95T | 5.41 | ― | 5.67% | -3.68% | 2.67% | |
70 Outperform | HK$2.86T | 5.61 | 9.18% | 5.46% | -3.35% | 0.58% | |
69 Neutral | HK$684.59B | 5.10 | 7.92% | 6.06% | -4.42% | -2.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
57 Neutral | HK$649.95B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% |